In
recent years, exome sequencing has become an important diagnostic tool in
genetics. Analyzing the protein-coding region of the genome, this test examines
the majority of disease-causing genes to identify disorders that would
otherwise be missed in individuals with multiple features not characteristic of
one particular syndrome or condition. However, with the scope of such a complex
test comes the possibility of genetic variants of uncertain clinical
significance (VUS) and incidental findings unrelated to a patient’s clinical
presentation. This complicates genetic counseling by adding more time,
paperwork, and complexity to the consent and disclosure processes.
I
developed my thesis project with assistance from my coworkers at the genetic testing
laboratory where I worked prior to graduate school and my mentors at the
University of Pittsburgh. Through developing my survey, I’ve learned important
skills. Reviewing literature has helped to guide the survey creation process,
and I’ve learned about specific ways in
which survey questions are coded to
help ease the process of statistical analysis, such as creating questions that
follow a “Likert scale”, e.g. Please rate how much you agree or disagree with
the following (1=strongly disagree, 5=strongly
agree).
In
addition, my thesis has forced me to think about my own opinions regarding this
testing, and to confront these opinions to help structure the questions in the
best possible manner. I hope that the results of this survey will help to
identify problem areas that should be addressed before prenatal exome
sequencing is offered by labs, as well as to show any similarities or
differences that develop from working in clinic versus working in the lab in
regards to opinions of new testing implementation.
-Tricia
Zion, class of 2016
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.